Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $97.46 USD
Change Today -1.49 / -1.51%
Volume 1.2M
As of 6:40 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harry Kirsch

Chief Financial Officer, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
48SFr.4,571,233
As of Fiscal Year 2014

Background*

Mr. Harry Kirsch has been the Chief Financial Officer of Novartis AG since May 1, 2013. Mr. Kirsch joined Novartis in 2003 and served as Chief Financial Officer of Pharmaceuticals until May 01, 2013. He served at Procter & Gamble. He serves as a Director of advisory board of Novartis Venture Funds. Mr. Kirsch studied industrial engineering and economics at the university of karlsruhe in Germany ("Diplom Wirtschaftsingenieur").

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Karlsruhe Institute of Technology

Other Affiliations*

Annual Compensation*

SalarySFr.829,167
BonusSFr.1,776,515
Total Annual CompensationSFr.2,605,682

Stock Options*

Long Term Incentive PlanSFr.1,785,045
All Other CompensationSFr.180,506

Total Compensation*

Total Annual Cash CompensationSFr.2,786,188
Total Short Term CompensationSFr.2,605,682
Other Long Term CompensationSFr.180,506
Total Calculated CompensationSFr.4,571,233
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $97.46 USD -1.49

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-SPONSORED ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.